| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.4 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.052 | 0.4 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.037 | 0.4 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.4 |